Information for Shareholders and Investors
About Grifols 
Divisions 
Worldwide 
Products and services 
Join us 
Press Room 
  News
  Grifols publishes interim results of its clinical trial on Alzheimer’s disease  9/22/2009
  Grifols launches Niuliva®  9/1/2009
  Grifols´net profit rose 31.4% in the first half of 2009 to 81.7 MM euros 7/29/2009
  Work recognised in the 2nd edition of the “Martín Villar Haemostasis Awards” 7/14/2009
Social Commitment
Dedicated to the community: Grifols applies sophisticated science and technology to improve people’s health and well-being.

Manufacturing


Contact | Site Map | Español

Search in:

 

Always nearby, always on time